TNF and rheumatoid arthritis: These results, taken together with the clinical finding that IL-6 levels were reduced in RA patients treated with TNF-α inhibitors, suggest that the inhibition of serum hepcidin-25 levels by TNF-α inhibitors in RA patients may be caused indirectly by a reduction in IL-6 production.